Clinical Trial Update: Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and efficacy results for intravitreal fluocinolone acetonide implants in patients with diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Fluocinolone acetonide implant (fluocinolone acetonide implant)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED